Outsourcing-Pharma

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com

>	China gaining ground in outsourcing supremacy
>	Contract manufacturing biz to exceed $26bn
>	Charles River Labs awarded $111.6m NCI contract
>	Cleveland BioLabs glowing after radioprotection drug deal
>	Synexus starts up in South Africa

Other top industry news

>	Inhalable insulin may be a 'flop', says report
>	Lilly injects $560m into US biotech plant expansion but will shut UK plant
>	Dry-powder inhaler 'revolution' unveiled
>	Big pharma business model needs to change

	Outsourcing Pharma

Search Forward to a colleague		Tuesday 31 October 2006

Sponsored by Cardinal Health
Comprehensive Pulmonary & Nasal Dosage Forms
Cardinal Health offers comprehensive pulmonary and nasal development services to take your product from concept and feasibility studies through regulatory approval and commercial-scale manufacturing. Click Here

Access full stories

China gaining ground in outsourcing supremacy
A recent report has placed China as the country gaining significant grounds on the US in terms of R&D spending and outsourcing capabilities... Read

Contract manufacturing biz to exceed $26bn
The global contract manufacturing market is expected to exceed $26bn (€20bn) by 2011, according to new market research... Read

Charles River Labs awarded $111.6m NCI contract
Charles River Laboratories has been awarded a $111.6m (€89m), 10-year contract from the National Cancer Institute (NCI)... Read

Cleveland BioLabs glowing after radioprotection drug deal
US-based drug maker Cleveland BioLabs has teamed up with biopharmaceutical manufacturer Synco Bio Partners to produce its leading radioprotection molecule for clinical trials and commercialisation... Read

Synexus starts up in South Africa
UK-based Synexus Clinical Research is continuing its global movements with the latest acquisition of South African outfit Clinical Research Centers (CRC)... Read

All News Headlines for: October | September | August

Sponsored by SF-Chem
High-quality intermediates
SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Previous Headlines

>	Cardinal claims to hold the ke ...

>	Contract packaging a€? a ...

>	Intertek ASG expands biopharma ...

>	A world of outsourcing awaits ...

>	Curalogic appoints SAFC to pro ...

>	Clinphone heads down under ...

>	A world of outsourcing awaits ...

>	A world of outsourcing awaits ...

>	Big Pharma splash out on R&D ...

>	FDA to review electronic signa ...

Product Categories

>	Product & Supplier News - Contract Manufacturing

Related Web Sites

>	In-PharmaTechnologist.com

>	DrugResearcher.com

>	BioPharmaReporter.com



>	All our Websites

Other top industry news

Inhalable insulin may be a 'flop', says report
Inhalable insulin is unlikely to achieve the blockbuster status the industry had hoped for, according to a new Datamonitor report... Read

Lilly injects $560m into US biotech plant expansion but will shut UK plant
Drug maker Eli Lilly has completed the first phase of a $560m (€446m) expansion of its biotech facility in Indianapolis, US, in order to match the growing number of biological drugs in its pipeline... Read

Dry-powder inhaler 'revolution' unveiled
A new dry powder inhaler that may cost less than a syringe and deliver 40 per cent more active drug than current inhalers has been unveiled by its maker, Cambridge Consultants... Read

Big pharma business model needs to change
The current big pharma business model is not sustainable for the future and will need to change, delegates heard at the recent Financial Times (FT) global Pharmaceuticals and Biotechnology Conference... Read

Events - Publisher's Choice

STAY up-to-date with pharmaceutical Innovations
Visit our regularly updated events calendar and learn about important events within the industry today ... Read

ELNS & Laboratory Informatics
4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read

Sponsored by Cardinal Health
Cardinal Health enhances drug delivery
Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here

Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences \| Change your email address \| ***
	Contact us: Advertising \| Recruitment \| Privacy policy \| Terms & conditions \| Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

Back to newsletter list

Date:

From:

Subject:

31/10 China/Manufacturing/Cancer/radioprotection drugs/South Africa